Turning science into business: An optimised alternative to antibodies
Drug Discovery World
APRIL 3, 2023
From humble beginnings in the founder’s basement, UK-based Aptamer Group is now supplying its Optimer binders to clients across big pharma. As life science operates globally, the vision for the business was always to bring aptamers as an antibody alternative to researchers worldwide. To what do you attribute your success?
Let's personalize your content